Barcelona, Spain

Oriol Bestard Matamoros

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oriol Bestard Matamoros: Innovator in Antibody Detection

Introduction

Oriol Bestard Matamoros is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of biomedical research, particularly in the detection of antibody-secreting B cells. His innovative work has implications for organ transplantation and immunology.

Latest Patents

Oriol Bestard Matamoros holds a patent titled "Method for detecting antibody-secreting B cells specific for HLA." This invention relates to methods for detecting antibody-secreting B cells that are specific for at least one human leukocyte antigen (HLA) in a subject. The patent also encompasses kits designed for these methods and their applications in determining the risk of humoral rejection against allogeneic transplants. Additionally, it aids in assessing the risk of endarteritis associated with post-transplant humoral rejection and helps in selecting suitable transplant candidates.

Career Highlights

Oriol Bestard Matamoros is affiliated with the Institut D'Investigacio Biomedica De Bellvitge (IDIBELL), where he conducts his research. His work is crucial in advancing the understanding of immune responses in transplant patients. He has been recognized for his innovative approaches and contributions to the field.

Collaborations

Oriol collaborates with esteemed colleagues, including Marc Lúcia Perrez and Josep Maria Grinyó Boira. Their combined expertise enhances the research efforts at IDIBELL and contributes to the development of new methodologies in biomedical research.

Conclusion

Oriol Bestard Matamoros is a key figure in the field of antibody detection, with a focus on improving transplant outcomes through innovative methods. His contributions are vital for advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…